Kura Oncology (KURA) Change in Acquisitions & Divestments (2023 - 2026)

Kura Oncology has reported Change in Acquisitions & Divestments over the past 4 years, most recently at $147.5 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 11.99% to $147.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $735.0 million through Mar 2026, up 17.47% year-over-year, with the annual reading at $755.1 million for FY2025, 35.34% up from the prior year.
  • Change in Acquisitions & Divestments was $147.5 million for Q1 2026 at Kura Oncology, down from $177.5 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $235.0 million in Q3 2025 and troughed at $85.0 million in Q1 2023.
  • The 4-year median for Change in Acquisitions & Divestments is $146.0 million (2024), against an average of $145.1 million.
  • Year-over-year, Change in Acquisitions & Divestments skyrocketed 119.33% in 2024 and then decreased 14.57% in 2025.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $141.9 million in 2023, then increased by 2.89% to $146.0 million in 2024, then grew by 21.58% to $177.5 million in 2025, then decreased by 16.9% to $147.5 million in 2026.
  • Per Business Quant, the three most recent readings for KURA's Change in Acquisitions & Divestments are $147.5 million (Q1 2026), $177.5 million (Q4 2025), and $235.0 million (Q3 2025).